Schonfeld Strategic Advisors LLC - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,394,000
+3387.3%
290,416
+1522.4%
0.04%
+3600.0%
Q4 2021$126,000
-84.3%
17,900
-67.2%
0.00%
-90.9%
Q2 2020$804,000
-81.5%
54,512
-69.7%
0.01%
-89.6%
Q4 2019$4,354,000
+157.6%
180,148
+104.9%
0.11%
+112.0%
Q3 2019$1,690,000
+194.4%
87,900
+644.9%
0.05%
-3.8%
Q3 2017$574,000
+68.8%
11,801
+57.4%
0.05%
+52.9%
Q1 2017$340,000
-78.4%
7,498
-82.0%
0.03%
-83.3%
Q4 2016$1,575,000
+79.6%
41,594
+79.0%
0.20%
+36.9%
Q3 2016$877,000
+315.6%
23,231
+93.8%
0.15%
+217.0%
Q2 2016$211,00011,9900.05%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders